TetraLogic Announces Pricing of Initial Public Offering of Common Stock
Print
Alert
TETRALOGIC PHARMACEUTICALS CORP (NASDAQ:TLOG)
Intraday Stock Chart
Today : Thursday 12 December 2013
Click Here for more TETRALOGIC PHARMACEUTICALS CORP Charts.
TetraLogic Pharmaceuticals Corporation (TetraLogic) today announced pricing of its initial public offering of 7,150,000 shares of its common stock at a public offering price of $7.00 per share, before underwriting discount and offering costs. All of the shares of common stock are being offered by TetraLogic. In addition, TetraLogic has granted the underwriters a 30-day option to purchase up to an additional 1,072,500 shares of common stock at the same price to cover over-allotments, if any. The shares are expected to begin trading on the NASDAQ Global Market on December 12, 2013 under the symbol "TLOG."
The offering is expected to close on December 17, 2013, subject to customary closing conditions.
Oppenheimer & Co. Inc., Guggenheim Securities, LLC and Needham & Company, LLC are acting as joint book-running managers for the offering.
TetraLogic intends to use the net proceeds of its initial public offering to advance the clinical and pre-clinical development of birinapant, other development programs, working capital and general corporate purposes.
TetraLogic has filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commission (SEC) relating to the common stock being sold in the offering. The registration statement was declared effective by the SEC on December 11, 2013. The offering is being made only by means of a prospectus, copies of which may be obtained from:
